Dock foredragar vissa utovare att injicera nara skadeplatsen (subkutant eller intramuskulart) for lokala koncentrationsfordelar, sarskilt for sen- och ligamentskador
BPC-157: nitric oxide, angiogenesis, tendon-fibroblast outgrowth BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide first characterized by the Sikiric group at the University of Zagreb beginning in the early 1990s
GHK-Cu acts as a copper-binding signalling peptide that modulates the expression of thousands of genes involved in collagen remodelling, antioxidant defence, and tissue repair
Is this a concept that you think, I mean certainly most tumors, if they become metastatic, you just can't give enough chemo, you can't give enough targeted therapy, enough immunotherapy, doesn't matter what it is
It is not intended for human consumption, diagnostic use, or therapeutic application